Universal Corporation
NYSE:UVVTobacco
-$0.54 today
- Market cap
- $877.18M
- Beta
- 0.57
- P/E (TTM)
- 40.1
- EPS (TTM)
- $1.30
- Dividend yield
- 6.27%
Volume 0.64M
Average 0.22M
UVV Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Universal CorporationNYSE: UVV
Research & Development · Q4 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q4 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2026, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2026 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 0 | — |
| FY2025 | 2025-03-31 | 0 | — |
| FY2024 | 2024-03-31 | 0 | — |
| FY2023 | 2023-03-31 | 0 | — |
| FY2022 | 2022-03-31 | 0 | — |
Research & Development vs competitors
How UVV compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Research & development amounts to 0.0% of revenue for UVV, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥527.45M CNY | +9.0% | -13.8% | 8.8% | |
| LTM Mar 2026 | $123.4M USD | -2.8% | -9.7% | 15.9% | |
| LTM Jun 2026 | $10.7M USD | -59.8% | — | 0.4% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | R$0 BRL | -100.0% | — | 0.0% | |
PXEDPhoenix Education Partners, Inc | LTM Feb 2026 | $0 USD | — | — | 0.0% |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UVV) | — | -79.9% | -11.8% | 0.0% | |
Competitors are the stored peer set for UVV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 2.1B | 2.57B | 2.75B | 2.95B | 2.92B |
| Cost of Revenue | 1.69B | 2.11B | 2.21B | 2.4B | 2.41B |
| Gross Profit | 408.93M | 458.29M | 536.1M | 548.88M | 512.02M |
| Gross Margin | 19.4% | 17.8% | 19.5% | 18.6% | 17.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 240.69M | 277.21M | 310.57M | 302.37M | 300.67M |
| Operating Expenses | 248.61M | 277.21M | 314.09M | 304.72M | 300.67M |
| Depreciation & Amortization | 52.52M | 57.3M | 58.33M | 59.77M | 53.44M |
| EBITDA | 222.54M | 248.57M | 288.68M | 301.05M | 230.13M |
| EBITDA Margin | 10.6% | 9.7% | 10.5% | 10.2% | 7.9% |
| Operating Income | 160.32M | 181.07M | 222.01M | 244.15M | 211.35M |
| Operating Margin | 7.6% | 7.0% | 8.1% | 8.3% | 7.2% |
| Interest Income | 917K | 6.02M | 4.5M | 3.48M | 1.96M |
| Interest Expense | 27.75M | 49.3M | 66.27M | 87.07M | 74.04M |
| Other Income / Expenses | (18.05M) | (39.1M) | (57.93M) | (89.94M) | (108.69M) |
| Income Before Tax | 142.27M | 141.97M | 164.08M | 154.22M | 102.65M |
| Pre-Tax Margin | 6.8% | 5.5% | 6.0% | 5.2% | 3.5% |
| Income Tax Expense | 38.66M | 11.73M | 31.11M | 40.95M | 46.66M |
| Net Income | 86.58M | 124.05M | 119.6M | 95.05M | 32.64M |
| Net Margin | 4.1% | 4.8% | 4.4% | 3.2% | 1.1% |
| EPS (Basic) | 3.50 | 5.01 | 4.81 | 3.81 | 1.30 |
| EPS (Diluted) | 3.47 | 4.97 | 4.78 | 3.78 | 1.30 |
| Weighted Avg Shares | 24.76M | 24.77M | 24.85M | 24.95M | 25.06M |
| Weighted Avg Shares (Diluted) | 24.92M | 24.94M | 25.04M | 25.13M | 25.19M |
Universal Corporation
NYSE:UVV
Intrinsic Alpha fair value
Locked
Current Price
$35.19
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.